Charles Wallace Abbott Joins Rush to Buy Emerging-Markets Pharmaceuticals Makers U.S. and non-U.S. pharmaceuticals companies are on the prowl to expand their portfolios in the developing world, where growth is 3 times higher than in the industrialized West. Charles Wallace December 9, 2010